Di (2-Etilhekzil) Fitalatın Pubertal Dönemdeki

Total Page:16

File Type:pdf, Size:1020Kb

Di (2-Etilhekzil) Fitalatın Pubertal Dönemdeki Dİ (2-ETİLHEKZİL) FİTALATIN PUBERTAL DÖNEMDEKİ ERKEK SIÇANLARDA GENOTOKSİK, HİSTOLOJİK VE BİYOKİMYASAL ETKİLERİNİN ARAŞTIRILMASI INVESTIGATION OF GENOTOXIC, HISTOLOGIC AND BIOCHEMICAL EFFECTS OF DI (2-ETHYLHEXYL) PHTHALATE ON PUBERTAL MALE RATS GÖZDE KARABULUT Prof. Dr. NURHAYAT BARLAS Tez Danışmanı Hacettepe Üniversitesi Lisansüstü Eğitim – Öğretim ve Sınav Yönetmeliğinin Biyoloji Anabilim Dalı için Öngördüğü YÜKSEK LĠSANS TEZĠ olarak hazırlanmıştır. 2014 GÖZDE KARABULUT ’un hazırladığı “Dİ (2-ETİLHEKZİL) FİTALATIN PUBERTAL DÖNEMDEKİ ERKEK SIÇANLARDA GENOTOKSİK, HİSTOLOJİK VE BİYOKİMYASAL ETKİLERİNİN ARAŞTIRILMASI ʺ adlı bu çalışma aşağıdaki jüri tarafından BİYOLOJİ ANABİLİM DALI ’nda YÜKSEK LİSANS TEZİ olarak kabul edilmiştir. Prof. Dr. Dürdane KOLANKAYA Başkan Prof. Dr. Nurhayat BARLAS Danışman Prof. Dr. Güldeniz SELMANOĞLU Üye Prof. Dr. Arzu KOÇKAYA Üye Prof. Dr. Ġsmet ÇOK Üye Bu tez Hacettepe Üniversitesi Fen Bilimleri Enstitüsü tarafından YÜKSEK LİSANS TEZİ olarak onaylanmıştır. Prof. Dr. Fatma SEVĠN DÜZ Fen Bilimleri Enstitüsü Müdürü Canım Aileme… ETİK Hacettepe Üniversitesi Fen Bilimleri Enstitüsü, tez yazım kurallarına uygun olarak hazırladığım bu tez çalışmasında; tez içindeki bütün bilgi ve belgeleri akademik kurallar çerçevesinde elde ettiğimi, görsel, işitsel ve yazılı tüm bilgi ve sonuçları bilimsel ahlak kurallarına uygun olarak sunduğumu, başkalarının eserlerinden yararlanılması durumunda ilgili eserlere bilimsel normlara uygun olarak atıfta bulunduğumu, atıfta bulunduğum eserlerin tümünü kaynak olarak gösterdiğimi, kullanılan verilerde herhangi bir tahrifat yapmadığımı, ve bu tezin herhangi bir bölümünü bu üniversite veya başka bir üniversitede başka bir tez çalışması olarak sunmadığımı beyan ederim. 09/09/2014 GÖZDE KARABULUT ÖZET Dİ (2-ETİLHEKZİL) FİTALATIN PUBERTAL DÖNEMDEKİ ERKEK SIÇANLARDA GENOTOKSİK, HİSTOLOJİK VE BİYOKİMYASAL ETKİLERİNİN ARAŞTIRILMASI Gözde KARABULUT Yüksek Lisans, Biyoloji Bölümü Tez Danışmanı: Prof. Dr. Nurhayat Barlas Eylül 2014, 104 sayfa Bu çalıĢmada, plastikleĢtirici olarak kullanılan ve gündelik hayatta sıkça maruz kalınan 2-etilhekzilfitalat’ın (DEHP) pubertal dönemdeki erkek sıçanlarda genotoksik etkileri Comet testi ile araĢtırılmıĢ, histopatolojik, hematolojik ve biyokimyasal analizler yapılarak incelenmiĢtir. Bu amaçla sıçanlar her grupta 6 hayvan olacak Ģekilde, pozitif kontrol (MMS), yağ kontrol, 100 mg/kg/gün, 200 mg/kg/gün ve 400 mg/kg/gün uygulama gruplarına ayrılmıĢ ve 28 gün süreyle sıçanlara DEHP gavaj yoluyla oral uygulanmıĢtır. Deney sonuna kadar her hafta alınan kan örneklerinde genotoksik analiz yapılmıĢtır. Deney süresince sıçanlarda vücut ağırlığı, yem ve su tüketimleri ölçülmüĢtür. Deney süresi sonunda sıçanlardan alınan serum örneklerinde alanin aminotransferaz (ALT), aspartat transaminaz (AST), üre, ürik asit, trigliserit, glikoz, kreatinin miktarları ölçülmüĢtür. Ayrıca kanda hematolojik analiz yapılmıĢtır. Karaciğer ve böbrek dokularında oluĢabilecek histopatolojik etkiler ıĢık mikroskobunda incelenmiĢ ve değiĢik büyütmeler ile görüntülenmiĢtir. DEHP uygulanan gruplarda DNA hasarı oluĢumu kontrol grubuna göre yüksek bulunmuĢtur. Trigliserit seviyelerinin de kontrol grubuna göre anlamlı olarak yüksek olduğu saptanmıĢtır. Yapılan histopatolojik incelemeler, DEHP’in böbrekte ve karaciğerde histopatolojik değiĢikliklere neden olduğunu ortaya koymuĢtur. Anahtar Kelimeler: Di (2-etilhekzil) Fitalat, Genotoksisite, Comet Testi, Sıçan, Karaciğer, Böbrek. i ABSTRACT INVESTIGATION OF GENOTOXIC, HISTOLOGIC AND BIOCHEMICAL EFFECTS OF DI (2- ETHYLHEXYL) PHTHALATE ON PUBERTAL MALE RATS Gözde KARABULUT Master of Science, Department of Biology Supervisor: Prof. Dr. Nurhayat Barlas September 2014, 104 pages In the present study, we investigated the genotoxic effects of DEHP which is widely used as a plasticizer and people were exposed in daily life on pubertal male rats. These effects were investigated with Comet assay and histopathological, hematological and biochemical analysis were investigated. For this purpose, rats were divided into 5 groups and each group had 6 animals. The dose groups were oil control, positive control (MMS), 100 mg/kg/day, 200 mg/kg/day and 400 mg/kg/day of DEHP. It was administered daily to the rats by oral gavage for 28 days and every week until the end of the experiment, genotoxic effect was measured in blood. During the experiment, body weights and feed and water consumption were recorded. At the end of the experiment blood samples were taken and hematological analysis, alanine aminotransferase (ALT), aspartate aminotransferase (AST), ure, uric acid, trigliserid, glucose, creatinine were determined in serum. Kidney and liver were dissected and tissues were investigated potential histopathologic findings and monitorized in different magnifications by the Leica light microscopy. DNA damage level was statistically different from treatment groups compared to the oil control. Triglycerid levels were also significantly higher in HFCS and sucrose groups. Histopathological examinations revealed histopathological changes in kidney and liver of rats received DEHP. Keywords: Di (2-ethylhexyl) Phthalate, Genotoxicity, Comet Assay, Rat, Liver, Kidney. ii TEŞEKKÜR ÇalıĢmam süresince beni yönlendiren, bilgi ve tecrübelerini benimle paylaĢarak bana her konuda yardımcı olan ve desteğini esirgemeyen çok değerli danıĢman hocam Sayın Prof. Dr. Nurhayat BARLAS’a, Tezimin son halini almasında önerileri ile beni yönlendiren çok değerli jüri üyelerine, Comet testi analizlerinin yapılabilmesi için bize laboratuvarını açan sayın hocam Prof. Dr. Ġsmet ÇOK’a ve analizlerin hepsinde yanımda olup yardımcı olan sevgili uzman biyolog arkadaĢım GülĢen GÖNEY’e Deneylerimde ve her konuda bana yardımcı olup yol gösteren sevgili Egemen FOTO ve AraĢ. Gör. Fatma ZĠLĠFDAR’a, Tezimin deneysel aĢamalarında yanımda olan ve yardımlarını esirgemeyen, değerli arkadaĢlarım Eylül TURASAN, Pınar KAÇAMAK ve Elnaz YOUSEFĠ ARDEBĠLĠ’ye Yardımlarını hiçbir zaman esirgemeyen baĢta oda arkadaĢım AraĢ. Gör. Mehmet KürĢat ġAHĠN olmak üzere tüm Hacettepe Üniversitesi Biyoloji Bölümü Zooloji Anabilim Dalı Öğretim Üyeleri ve Yardımcılarına, Ne zaman arasam hemen koĢarak gelen ve tez içinde ve dıĢında her konuda destek ve yardımcı olan canım kuzenim Damla Ceren AKIN’a, her konuda yanımda olup bana destek olan sonsuz güvendiğim canım teyzelerim Reyhan AKIN ve ġükran ÖZDEMĠR’e, Lisans döneminden beri yanımda olan, iyi ve kötü her anımı paylaĢtığım, her ihtiyacımda bir telefon kadar yakın olan canım dostlarım AraĢ. Gör. Hasan ÇALIġKAN, Zeliha YILMAZ ve AraĢ. Gör. Merve ÖZCAN’a, Yüksek lisansa baĢladığım günden beri birlikte güldüğüm, üzüldüğüm, sevindiğim, gezdiğim, eğlendiğim kısacası her anımı paylaĢtığım değerli dostlarım Derya AKKURT ve AraĢ. Gör. Sevcan ALDEMĠR’e, Beni gittiği her yolculukta yanında götüren ve bu sayede uçak fobimi yenmemi sağlayan, her arayıĢımda bana güç veren ve güldüren, değerli hediyeleriyle beni Ģımartan değerli dostum Av. Ġpek GENÇOĞLU’na, iii Her Ģeyden önemlisi, hayatımın bütün anlarında yanımda olan, maddi ve manevi olarak hep beni destekleyen, güvenini hep hissettiğim canım babam Sermet KARABULUT’a, beni büyütüp bugünlere getiren, her zaman arkamda olduğunu bilip güvenini her zaman hissettiğim, dünyanın en fedakar annesi olan canım annem Nuran KARABULUT’a, her konuda bana akıl ve fikir verip yol gösteren, olgunluğuyla bana çok Ģey katan ve yukarılara çıkaran, onsuz bir hayat düĢünemediğim canım yol arkadaĢım, canımın içi kardeĢim Aslı KARABULUT’a sonsuz teĢekkür ederim. Gözde KARABULUT Ankara, Eylül 2014 iv İÇİNDEKİLER Sayfa ÖZET……………………………………………………………………………………...i ABSTRACT……………………………………………………………………………...ii TEġEKKÜR……………………………………………………………………………...iii ĠÇĠNDEKĠLER…………………………………………………………………………....v 1.GĠRĠġ .............................................................................................................. 1 2. GENEL BĠLGĠLER…………………………………………………………………...3 2.1.ENDOKRĠN BOZUCULAR ........................................................................... 3 2.1.1.Fitalatlar ..................................................................................................... 8 2.1.1.1.Fitalatların Biyotransformasyonları ....................................................... 13 2.1.1.2.Fitalatların Yaptığı Toksik Etkiler .......................................................... 14 2.1.1.3 Di (2-etilhekzil) Fitalat .......................................................................... 16 2.1.1.3.1 DEHP’ in Metabolizması......................................................................19 2.1.1.3.2 DEHP ve Toksisitesi .......................................................................... 20 2.1.1.3.3 DEHP ve DNA Hasarı ........................................................................ 21 2.2. Genetik Toksikoloji……………………………………….................................22 2.2.1. DNA Hasarı..............................................................................................24 2.2.2. Genotoksisitenin Karsinojenezisle ĠliĢkisi.................................................27 2.2.3. Sık Kullanılan Bazı Genotoksisite Testleri...............................................28 2.2.3.1 Kromozomal aberasyon (CA) testi ........................................................ 29 2.2.3.2. Mikroçekirdek Testi.............................................................................. 29 2.2.3.3.KardeĢ Kromatid DeğiĢimi (Sister chromatid Exchange=SCE)............. 29 2.2.3.4. COMET Tekniği (Single Cell Jel Elektroforez Tekniği) ........................ 29
Recommended publications
  • Amorpha Fruticosa – a Noxious Invasive Alien Plant in Europe Or a Medicinal Plant Against Metabolic Disease?
    fphar-08-00333 June 6, 2017 Time: 18:44 # 1 REVIEW published: 08 June 2017 doi: 10.3389/fphar.2017.00333 Amorpha fruticosa – A Noxious Invasive Alien Plant in Europe or a Medicinal Plant against Metabolic Disease? Ekaterina Kozuharova1, Adam Matkowski2, Dorota Wo´zniak2, Rumiana Simeonova3, Zheko Naychov4, Clemens Malainer5, Andrei Mocan6,7, Seyed M. Nabavi8 and Atanas G. Atanasov9,10,11* 1 Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria, 2 Department of Pharmaceutical Biology with Botanical Garden of Medicinal Plants, Medical University of Wroclaw, Poland, 3 Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria, 4 Sofia University St. Kliment Ohridski, Faculty of Medicine, Department of Surgery, Obstetrics and Gynecology, Division of Cardiac Surgery, University Hospital Lozenetz, Sofia, Bulgaria, 5 Independent Researcher, Vienna, Austria, 6 Department of Pharmaceutical Botany, Iuliu Ha¸tieganuUniversity of Medicine and Pharmacy, Cluj-Napoca, Romania, 7 ICHAT and Institute for Life Sciences, University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania, 8 Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran, 9 Institute of Genetics and Animal Breeding, Polish Academy of Sciences, Jastrzebiec, Poland, 10 Department of Pharmacognosy, University of Vienna, Vienna, Austria, 11 Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria Amorpha fruticosa L. (Fabaceae) is a shrub native to North America which has been Edited by: Kalin Yanbo Zhang, cultivated mainly for its ornamental features, honey plant value and protective properties University of Hong Kong, Hong Kong against soil erosion.
    [Show full text]
  • Flavonoid Glucodiversification with Engineered Sucrose-Active Enzymes Yannick Malbert
    Flavonoid glucodiversification with engineered sucrose-active enzymes Yannick Malbert To cite this version: Yannick Malbert. Flavonoid glucodiversification with engineered sucrose-active enzymes. Biotechnol- ogy. INSA de Toulouse, 2014. English. NNT : 2014ISAT0038. tel-01219406 HAL Id: tel-01219406 https://tel.archives-ouvertes.fr/tel-01219406 Submitted on 22 Oct 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Last name: MALBERT First name: Yannick Title: Flavonoid glucodiversification with engineered sucrose-active enzymes Speciality: Ecological, Veterinary, Agronomic Sciences and Bioengineering, Field: Enzymatic and microbial engineering. Year: 2014 Number of pages: 257 Flavonoid glycosides are natural plant secondary metabolites exhibiting many physicochemical and biological properties. Glycosylation usually improves flavonoid solubility but access to flavonoid glycosides is limited by their low production levels in plants. In this thesis work, the focus was placed on the development of new glucodiversification routes of natural flavonoids by taking advantage of protein engineering. Two biochemically and structurally characterized recombinant transglucosylases, the amylosucrase from Neisseria polysaccharea and the α-(1→2) branching sucrase, a truncated form of the dextransucrase from L. Mesenteroides NRRL B-1299, were selected to attempt glucosylation of different flavonoids, synthesize new α-glucoside derivatives with original patterns of glucosylation and hopefully improved their water-solubility.
    [Show full text]
  • Characterization of the Isoflavone Pratensein As a Novel
    July 2009 Notes Biol. Pharm. Bull. 32(7) 1289—1294 (2009) 1289 Characterization of the Isoflavone Pratensein as a Novel Transcriptional Up-Regulator of Scavenger Receptor Class B Type I in HepG2 Cells # # Yuan YANG, Wei JIANG, Li WANG, Zhong-Bing ZHANG, Shu-Yi SI,* and Bin HONG* Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College; Beijing 100050, China. Received January 22, 2009; accepted April 9, 2009; published online April 15, 2009 Scavenger receptor class B type I (SR-BI), as well as its human homologue CLA-1, plays an important role in reverse cholesterol transport (RCT) as high density lipoprotein (HDL) receptor. Using a previously developed cell-based screening model for CLA-1 up-regulators, pratensein, was shown to present activity in elevating CLA- 1 transcriptional level. In this study, three other isoflavones including formononetin, genistein and daidzein were also shown to up-regulate CLA-1 transcriptional activity in the cell-based reporter assay. The effects of praten- sein on up-regulating CLA-1 expression were demonstrated at both mRNA and protein levels, and validated by its increasing of 1,1؅-dioctadecyl-3,3,3؅,3؅-tetramethylindocarbocyanine perchlorate-labeled (DiI)-HDL uptake in HepG2 cells. Furthermore, the cis-elements responsible for the pratensein up-regulatory effects were mapped to the ؊1055/؊182 bp fragment of CLA-1 promoter in HepG2 cells. These findings might provide a new molecular mechanism by which isoflavones potentially prevent atherosclerosis. Key words pratensein; scavenger receptor class B type I; reverse cholesterol transport; atherosclerosis; cis-element Cardiovascular disease is one of the most common dis- is beneficial in post-menopausal women for bone, cardiovas- eases that damage human health in developed countries and cular risk and hot flashes.9) The hypolipidemic activity of most developing countries, while atherosclerosis is the prin- pratensein has been reported in Triton-WR1339-induced hy- cipal pathogenesis for many critical cardiovascular diseases.
    [Show full text]
  • IN SILICO ANALYSIS of FUNCTIONAL Snps of ALOX12 GENE and IDENTIFICATION of PHARMACOLOGICALLY SIGNIFICANT FLAVONOIDS AS
    Tulasidharan Suja Saranya et al. Int. Res. J. Pharm. 2014, 5 (6) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 – 8407 Research Article IN SILICO ANALYSIS OF FUNCTIONAL SNPs OF ALOX12 GENE AND IDENTIFICATION OF PHARMACOLOGICALLY SIGNIFICANT FLAVONOIDS AS LIPOXYGENASE INHIBITORS Tulasidharan Suja Saranya, K.S. Silvipriya, Manakadan Asha Asokan* Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Viswa Vidyapeetham University, AIMS Health Sciences Campus, Kochi, Kerala, India *Corresponding Author Email: [email protected] Article Received on: 20/04/14 Revised on: 08/05/14 Approved for publication: 22/06/14 DOI: 10.7897/2230-8407.0506103 ABSTRACT Cancer is a disease affecting any part of the body and in comparison with normal cells there is an elevated level of lipoxygenase enzyme in different cancer cells. Thus generation of lipoxygenase enzyme inhibitors have suggested being valuable. Individual variation was identified by the functional effects of Single Nucleotide Polymorphisms (SNPs). 696 SNPs were identified from the ALOX12 gene, out of which 73 were in the coding non-synonymous region, from which 8 were found to be damaging. In silico analysis was performed to determine naturally occurring flavonoids such as isoflavones having the basic 3- phenylchromen-4-one skeleton for the pharmacological activity, like Genistein, Diadzein, Irilone, Orobol and Pseudobaptigenin. O-methylated isoflavones such as Biochanin, Calycosin, Formononetin, Glycitein, Irigenin, 5-O-Methylgenistein, Pratensein, Prunetin, ψ-Tectorigenin, Retusin and Tectorigenine were also used for the study. Other natural products like Aesculetin, a coumarin derivative; flavones such as ajoene and baicalein were also used for the comparative study of these natural compounds along with acteoside and nordihydroguaiaretic acid (antioxidants) and active inhibitors like Diethylcarbamazine, Zileuton and Azelastine as standard for the computational analysis.
    [Show full text]
  • Ginkgo Biloba L., Induces Neuronal Differentiation of Cultured PC12 Cells: Potentiating the Effect of Nerve Growth Factor
    Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2012, Article ID 278273, 11 pages doi:10.1155/2012/278273 Research Article Isorhamnetin, A Flavonol Aglycone from Ginkgo biloba L., Induces Neuronal Differentiation of Cultured PC12 Cells: Potentiating the Effect of Nerve Growth Factor Sherry L. Xu, Roy C. Y. Choi, Kevin Y. Zhu, Ka-Wing Leung, Ava J. Y. Guo, Dan Bi, Hong Xu, David T. W. Lau, Tina T. X. Dong, and Karl W. K. Tsim Division of Life Science and Center for Chinese Medicine, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong Correspondence should be addressed to Karl W. K. Tsim, [email protected] Received 6 March 2012; Accepted 11 April 2012 Academic Editor: Paul Siu-Po Ip Copyright © 2012 Sherry L. Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Flavonoids, a group of compounds mainly derived from vegetables and herbal medicines, share a chemical resemblance to estrogen, and indeed some of which have been used as estrogen substitutes. In searching for possible functions of flavonoids, the neuroprotective effect in brain could lead to novel treatment, or prevention, for neurodegenerative diseases. Here, different subclasses of flavonoids were analyzed for its inductive role in neurite outgrowth of cultured PC12 cells. Amongst the tested flavonoids, a flavonol aglycone, isorhamnetin that was isolated mainly from the leaves of Ginkgo biloba L. showed robust induction in the expression of neurofilament, a protein marker for neurite outgrowth, of cultured PC12 cells.
    [Show full text]
  • Phylogenetic Insights on the Isoflavone Profile Variations In
    Food Research International 76 (2015) 51–57 Contents lists available at ScienceDirect Food Research International journal homepage: www.elsevier.com/locate/foodres Phylogenetic insights on the isoflavone profile variations in Fabaceae spp.: Assessment through PCA and LDA Tatiana Visnevschi-Necrasov a,b, João C.M. Barreira b,c,⁎,SaraC.Cunhab, Graça Pereira d, Eugénia Nunes a, M. Beatriz P.P. Oliveira b a CIBIO-ICETA, Faculdade de Ciências, Universidade do Porto, R. Padre Armando Quintas 4485-661 Vairão, Portugal b REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, No. 228, 4050-313, Porto,Portugal c CIMO-ESA, Instituto Politécnico de Bragança, Campus de Santa Apolónia, Apartado 1172, 5301-855 Bragança, Portugal d INRB/IP — INIA — Instituto Nacional de Recursos Biológicos, Caia E São Pedro Estrada Gil Vaz, 7350-228 Elvas, Portugal article info abstract Article history: Legumes (Fabaceae) are important crops, known as sources of food, feed for livestock and raw materials for in- Received 30 September 2014 dustry. Their ability to capture atmospheric nitrogen during symbiotic processes with soil bacteria reduces the Received in revised form 15 November 2014 need for expensive chemical fertilizers, improving soil and water quality. Several Fabaceae species are acknowl- Accepted 20 November 2014 edged for the high levels of secondary metabolites. Isoflavones are among the most well-known examples of Available online 28 November 2014 these compounds, being recognized for their several types of biological activity. Herein, isoflavone profiles were characterized in nine species of four Fabaceae genera (Biserrula, Lotus, Ornithopus and Scorpiurus). Plants Chemical compounds studied in this article: fl Daidzin (PubChem CID: 107971) were harvested in the late ower physiological stage to prevent biased results due to naturally occurring varia- Genistin (PubChem CID: 5281377) tions along the vegetative cycle.
    [Show full text]
  • 23 Original Constituents and 147 Metabolites) of Astragali Radix Total Flavonoids and Their Distributions in Rats Using HPLC-DAD-ESI-IT-TOF-Msn
    Supplementary Materials Exploring the In Vivo Existence Forms (23 Original Constituents and 147 Metabolites) of Astragali Radix Total Flavonoids and Their Distributions in Rats Using HPLC-DAD-ESI-IT-TOF-MSn Li-Jia Liu, Hong-Fu Li, Feng Xu *, Hong-Yan Wang, Yi-Fan Zhang, Guang-Xue Liu, Ming-Ying Shang, Xuan Wang and Shao-Qing Cai * State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No. 38 Xueyuan Road, Beijing 100191, China; [email protected] (L.-J.L.); [email protected] (H.-F.L.); [email protected] (H.-Y.W.); [email protected] (Y.-F.Z); [email protected] (G.-X.L.); [email protected] (M.-Y. S); [email protected] (X.W.) * Correspondence: [email protected] (F.X.); [email protected] (S.-Q.C.); Tel.: +86-10-8280-2534 (F.X.); +86-10-8280-1693 (S.-Q.C.) 1. Supplementary Methods 1.1. Detailed Information on the Determination of the Contents of ARTF and its Major Constituents 1.1.1. ARTF Content Determination by HPLC-DAD-ELSD ARTF content determination was performed on a Shimadzu Prominence LC-20A liquid chromatograph system coupled with a low temperature ELSD, consisting of a DGU-20A3 degasser, an LC-20AD binary pump,an SIL-20A autosampler, a CBM-20A communications bus module, an SPD-M20A diode array detector, a CTO-20A column oven, and a low temperature ELSD-LT II detector. The chromatography separations were performed on an Industries Epic C18 column (250mm × 4.6 mm, 5 μm) (New Brunswick, NJ, USA) protected with an Agilent ZORBAX SB C18 guard column (12.5 mm × 4.6 mm, 5 μm) (Santa Clara, CA, USA).
    [Show full text]
  • Ep 3138585 A1
    (19) TZZ¥_¥_T (11) EP 3 138 585 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.03.2017 Bulletin 2017/10 A61L 27/20 (2006.01) A61L 27/54 (2006.01) A61L 27/52 (2006.01) (21) Application number: 16191450.2 (22) Date of filing: 13.01.2011 (84) Designated Contracting States: (72) Inventors: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB • Gousse, Cecile GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO 74230 Dingy Saint Clair (FR) PL PT RO RS SE SI SK SM TR • Lebreton, Pierre Designated Extension States: 74000 Annecy (FR) BA ME •Prost,Nicloas 69440 Mornant (FR) (30) Priority: 13.01.2010 US 687048 26.02.2010 US 714377 (74) Representative: Hoffmann Eitle 30.11.2010 US 956542 Patent- und Rechtsanwälte PartmbB Arabellastraße 30 (62) Document number(s) of the earlier application(s) in 81925 München (DE) accordance with Art. 76 EPC: 15178823.9 / 2 959 923 Remarks: 11709184.3 / 2 523 701 This application was filed on 29-09-2016 as a divisional application to the application mentioned (71) Applicant: Allergan Industrie, SAS under INID code 62. 74370 Pringy (FR) (54) STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES (57) The present specification generally relates to hydrogel compositions and methods of treating a soft tissue condition using such hydrogel compositions. EP 3 138 585 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 138 585 A1 Description CROSS REFERENCE 5 [0001] This patent application is a continuation-in-part of U.S.
    [Show full text]
  • Isoflavonoid Biosynthesis 21321.Pdf
    Isoflavonoid Biosynthesis https://www.kegg.jp/kegg-bin/highlight_pathway?scale=1.0&map=map00943&keyword=flavonoids Isoflavonoids are biologically active compounds, such as phytoestrogens, produced by pea family plants. While flavonoids (in the narrow sense) have the 2- phenylchromen-4-one backbone, isoflavonoids have the 3-phenylchromen-4-one backbone with no hydroxyl group substitution at position 2. Isoflavonoids are derived from the flavonoid biosynthesis pathway via liquiritigenin or naringenin. (Flavonoid Biosynthesis) -> [1,2] 1) Liquiritigenin -> [1,2,3] 1) flavone synthesis I & II -> 7,4’Dihydroxyflavone OR 2) flavonoid 6-hydroxylase -> 6,7,4’-Trihydroxyflavanone -> 2- hydroxyisoflavone synthase -> 2,6,7,4’-tetrahydroxyisoflavanone -> 6- Hydroxydaidzein -> Glycitein -> isoflavone 7-O-glucosyltransferase -> Glycitein 7-O-glucoside -> isoflavone 7-O-glucoside-6’’-O-malonyltransferase -> Glycitein 7-O-glucoside-6”-O-malonate OR 3) 2-hydroxyisoflavanone synthase -> 2,7,4’Trihydroxyisoflavanone -> [1,2] 1) Feedback Loop 2,7,4’-trihydroxyisoflavanone 4’-O-methyltransferase / isoflavone 4’-O-methyltransferase -> 2,7-Dihydroxy-4’-methoxyisoflavanone -> 2- hydroxyisoflavanone dehydratase -> Formononetin OR 2) 2-hydroxyisoflavone dehydratase -> Daidzein -> [1,2,3,4,5] 1) isoflavone/4’-methoxyisoflavone 2’-hydroxylase -> 2’Hydroxydaidzein -> 2’Hydroxydaidzein reductase -> 2’-Hydroxydihydrodaidzein -> 3,9-Dihydroxypterocarpan -> 3,9-dihydroxypterocarpan 6a-monooxygenase -> 3,6,9- Trihydroxypterocarpan -> [1,2] 1) trihydroxypterocarpan dimethylallyltransferase
    [Show full text]
  • PDF-Document
    Supplementary Materials 1 Metabolomics profiling analysis of red clover Table S1. Compound identification of red clover in positive and negative ion modes. MS1 No RT Ion Ion Measur Predicte Ste Le Flow Err MS2 MS3 Identification . min Form Formula ed d m af er ppm m/z m/z [M − 195.050 1 1.43 C6H11O7 195.0499 2.82 Gluconic acid ++ ++ +++ H]- 5 179.03506(C9H7O4); Benzoylcitronensa [M − 295.045 295.0448 ++ 2 4.46 C13H11O8 0.67 133.01451(C4H5O5); [295-179]135.04524(C8H7O2); ure ++ +++ H]- 0 4 + 115.00400(C4H3O4); [M + 355.102 ++ 3 5.42 C16H19O9 355.1024 1.21 chlorogenic acid + +++ H]+ 8 + [433-271]253.04956(C15H9O4); 243.06529(C14H11O4); [M + 433.111 Genistein- ++ 4 6.60 C21H21O10 433.1129 −3.54 271.06067(C15H11O5); 215.07042(C13H11O3); +++ +++ H]+ 4 glucoside + 153.01839(C7H5O4); 149.02335(C8H5O3); [M + 417.117 5 6.71 C21H21O9 417.1180 −2.34 239.07021(C15H11O3) daidzin + ++ +++ H]+ 0 [M + 447.127 calycosin-7-O-β-D- ++ 6 7.20 C22H23O10 447.1286 −1.91 269.08072(C16H13O4) +++ +++ H]+ 7 glucoside + 1 [533-285]270.05258(C15H10O5); Calycosin-7-O-β- [M + 533.127 253.04982(C15H9O4); ++ 7 8.03 C25H25O13 533.1290 −3.54 285.07642(C16H13O5); D-glucoside 4′′-O- +++ +++ H]+ 1 225.05478(C14H9O3); + malonate 137.02333(C7H5O3); [M + 433.112 ++ 8 8.95 C21H21O10 433.1129 −2.11 255.06516(C15H11O4) genistin ++ +++ H]+ 0 + [519-271]253.04958(C15H9O4,); Genistein- 243.06526(C14H11O4); [M + 519.111 433.11377(C21H21O10); glucoside ++ 9 9.31 C24H23O13 519.1133 −3.25 215.07045(C13H11O3); - +++ H]+ 6 271.06073(C15H11O5); malonate + 153.01833(C7H5O4); 149.02333(C8H5O3);
    [Show full text]
  • Phytochemical Profiling of Underexploited Fabaceae
    Food Research International 100 (2017) 517–523 Contents lists available at ScienceDirect Food Research International journal homepage: www.elsevier.com/locate/foodres Phytochemical profiling of underexploited Fabaceae species: Insights on the ontogenic and phylogenetic effects over isoflavone levels João C.M. Barreira a,b,⁎, Tatiana Visnevschi-Necrasov b,c, Graça Pereira d, Eugénia Nunes a, M. Beatriz P.P. Oliveira b a REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, no 228, 4050-313, Portugal b CIMO-ESA, Instituto Politécnico de Bragança, Campus de Santa Apolónia, Apartado 1172, 5301-855 Bragança, Portugal c CIBIO-ICETA, Faculdade de Ciências, Universidade do Porto, R. Padre Armando Quintas, 4485-661 Vairão, Portugal d INRB/IP - INIA - Instituto Nacional de Recursos Biológicos, Caia E São Pedro Estrada Gil Vaz, 7350-228 Elvas, Portugal article info abstract Article history: There is an increasing trend towards finding alternative sources of valued phytochemicals due to their diverse Received 27 January 2016 potentialities in food industry and pharmaceutical applications. Phenolic compounds, in particular, have been Received in revised form 1 July 2016 the focus of several profiling reports, but isoflavones characterization has been studied in fewer cases and in a Accepted 18 July 2016 very limited group of plant species. Despite their acknowledged bioactivity, there's actually a strict number of Available online 20 July 2016 plants validated for their isoflavones contents. In a previous report, we have identified nine Leguminosae species (from genera Biserrula, Lotus, Ornithopus and Scorpiurus) as potential alternative sources of these phenolic com- Keywords: fl fi Isoflavones profile pounds.
    [Show full text]
  • Lessons Learned
    Prevention and Reversal of Chronic Disease Copyright © 2019 RN Kostoff PREVENTION AND REVERSAL OF CHRONIC DISEASE: LESSONS LEARNED By Ronald N. Kostoff, Ph.D., School of Public Policy, Georgia Institute of Technology 13500 Tallyrand Way, Gainesville, VA, 20155 [email protected] KEYWORDS Chronic disease prevention; chronic disease reversal; chronic kidney disease; Alzheimer’s Disease; peripheral neuropathy; peripheral arterial disease; contributing factors; treatments; biomarkers; literature-based discovery; text mining ABSTRACT For a decade, our research group has been developing protocols to prevent and reverse chronic diseases. The present monograph outlines the lessons we have learned from both conducting the studies and identifying common patterns in the results. The main product of our studies is a five-step treatment protocol to reverse any chronic disease, based on the following systemic medical principle: at the present time, removal of cause is a necessary, but not necessarily sufficient, condition for restorative treatment to be effective. Implementation of the five-step treatment protocol is as follows: FIVE-STEP TREATMENT PROTOCOL TO REVERSE ANY CHRONIC DISEASE Step 1: Obtain a detailed medical and habit/exposure history from the patient. Step 2: Administer written and clinical performance and behavioral tests to assess the severity of symptoms and performance measures. Step 3: Administer laboratory tests (blood, urine, imaging, etc) Step 4: Eliminate ongoing contributing factors to the chronic disease Step 5: Implement treatments for the chronic disease This individually-tailored chronic disease treatment protocol can be implemented with the data available in the biomedical literature now. It is general and applicable to any chronic disease that has an associated substantial research literature (with the possible exceptions of individuals with strong genetic predispositions to the disease in question or who have suffered irreversible damage from the disease).
    [Show full text]